- Asthma may be caused due to genetic, environmental factors or combination of both.
- North America, followed by Europe, has the largest market for asthma treatment.
- Growing demographics and economies in developing countries such as India and China are expected to lead growth of the asthma treatment market in Asia.
Asthma is a chronic inflammatory lung disease. Asthma affects persons of all ages, but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive to an allergic reaction. Asthma may be caused due to genetic, environmental factors or a combination of both.
Almost all asthma sufferers have allergies. Some of the allergens are house dust mites in carpets, bedding and furniture, pet dander, pollens, molds, air pollution, tobacco smoke, chemical irritants in the workplace and others.
Some of the symptoms of asthma are coughing, wheezing, trouble in breathing and chest tightness. On the basis of class of drug, asthma market can be segmented into bronchodilators, mast cell stabilizers, leukotriene antagonists, immunosuppressants and combination of ICS/LABA. Asthma can be classified into four categories which include exercise, childhood asthma, allergic asthma and occupational asthma. Some of the medication for asthma treatment includes short-acting beta2-agonists, oral corticosteroids, methyxanthines, long-acting bronchodilators, monoclonal antibodies, mast cell stabilizers, leukotriene modifiers and inhaled corticosteroids.
To Understand How Our Report Information Can Bring Difference, Ask for a brochure
North America, followed by Europe, has the largest market for asthma treatment due to the developed healthcare infrastructure, drug innovation and rise in aging population. In addition, technological advancements for the treatment of asthma and rise in asthma patients in this region are driving the North American asthma treatment market. Asia is expected to experience high growth rate in the asthma treatment market in next few years due to a growing number of asthma patients, increasing disposable income, rise in environmental pollution, increasing number of smokers and developing healthcare infrastructure in the region.
- Buy Research Report: Cough Suppressant Drugs Market to Witness a CAGR of 3.7% During the Forecast Period (2018 – 2026)
- Buy Research Report: Lab Automation Market to Reflect Impressive Growth in Pharmaceuticals and Biotechnology Industry
- Buy Research Report: Plasma Fractionation Market to Expand 1.5x through 2026, Convalescent Plasma (CP) Treatment amid COVID-19 to Inject Hope
- Buy Research Report: Medical Holography Market to Surge, Finds Significant Potential in Diagnosis of COVID-19
- Buy Research Report: Epinephrine Market to Exhibit at a CAGR of 11.0% Over the Forecast Period (2018 – 2026)
Increasing incidence of asthma cases, advanced inhaler devices, innovation in biological drugs, rise in the death rates, increasing pollution level and growing aging population are expected to drive the market for asthma treatment. In addition, increasing population of smokers, rise in disposable income, increasing awareness about the benefits of timely diagnosis of asthma and growing demand for better healthcare facilities are expected to drive the market for asthma treatment. However, increasing number of patent expiration of drugs, rise in use of generic drugs and high cost of asthma treatment are some of the major factors restraining growth of the global asthma treatment market.
Growing demographics and economies in developing countries such as India and China are expected
to lead growth of the asthma treatment market in Asia. In addition, demand for novel biologic drugs for asthma treatment, rise in need for personalized therapies to control severe asthma, increasing focus on contract manufacturing outsourcing (CMO), rise in awareness about the benefits of timely diagnosis and equipment available in the market for the detection of asthma and the need for low cost of asthma therapies are expected to offer new opportunities for the global asthma treatment market.
Increasing number of mergers and acquisitions, rise in number of collaborations and partnerships, rise in popularity of combination therapies and new product launches are some of the latest trends that have been observed in global asthma treatment market. Some of the major companies operating in the global asthma treatment market are AstraZeneca, Merck & Co., Chiesi Farmaceutici, GlaxoSmithKline, Novartis AG and F. Hoffmann-La Roche. In addition, some other companies operating in global asthma treatment market are Cipla, Dr. Reddy’s Laboratories, Actavis, Orchid Chemicals and Pharmaceuticals, Abbott and Pfizer.
To Gain More Insights & Stay Ahead Of The Competition, Buy Now